4//SEC Filing
Gagnon Gilles 4
Accession 0001209191-18-054844
CIK 0000831547other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 8:06 PM ET
Size
5.1 KB
Accession
0001209191-18-054844
Insider Transaction Report
Form 4
Gagnon Gilles
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-10-09$15.33/sh−10,000$153,349→ 72,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001546387
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 8:06 PM ET
- Size
- 5.1 KB